Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Cancer peptide vaccination, as an immunotherapeutic approach against solid tumors, is currently employed in several clinical research protocols. The underlying mechanism of peptide-based vaccines involves the generation of a T-cell immune response against tumor or enhancement of an endogenous antitumor immunity pre-existing in the host.
Cancer peptide vaccination, as an immunotherapeutic approach against solid tumors, is currently employed in several clinical research protocols. The underlying mechanism of peptide-based vaccines involves the generation of a T-cell immune response against tumor or enhancement of an endogenous antitumor immunity pre-existing in the host. With the ever increasing new cancer cases across the globe and the conventional treatment methods unable to cope up with the challenges posed by the tumor and their immune response evading techniques, cancer immunotherapy brings a ray of hope.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Peptide Cancer Vaccine market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Peptide Cancer Vaccine market. Detailed analysis of key players, along with key growth strategies adopted by Peptide Cancer Vaccine industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Generex Biotechnology
ISA Pharmaceuticals
BrightPath Biotherapeutics
Sellas
Boston Biomedical
Imugene
VAXON Biotech
Immatics
Ultimovacs
TapImmune
OncoTherapy Science
By Type:
Goserelin
Bortezomib
Leuprorelin
Others
By End-User:
Breast Cancer
Lung Cancer
Melanoma
Prostate Cancer
Others
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Peptide Cancer Vaccine Market
-
1.3 Market Segment by Type
-
1.3.1 China Peptide Cancer Vaccine Market Size and Growth Rate of Goserelin from 2016 to 2027
-
1.3.2 China Peptide Cancer Vaccine Market Size and Growth Rate of Bortezomib from 2016 to 2027
-
1.3.3 China Peptide Cancer Vaccine Market Size and Growth Rate of Leuprorelin from 2016 to 2027
-
1.3.4 China Peptide Cancer Vaccine Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Peptide Cancer Vaccine Market Size and Growth Rate of Breast Cancer from 2016 to 2027
-
1.4.2 China Peptide Cancer Vaccine Market Size and Growth Rate of Lung Cancer from 2016 to 2027
-
1.4.3 China Peptide Cancer Vaccine Market Size and Growth Rate of Melanoma from 2016 to 2027
-
1.4.4 China Peptide Cancer Vaccine Market Size and Growth Rate of Prostate Cancer from 2016 to 2027
-
1.4.5 China Peptide Cancer Vaccine Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Peptide Cancer Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Peptide Cancer Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Peptide Cancer Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Peptide Cancer Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Peptide Cancer Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Peptide Cancer Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Peptide Cancer Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Peptide Cancer Vaccine Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Peptide Cancer Vaccine by Major Types
-
3.4.1 Market Size and Growth Rate of Goserelin
-
3.4.2 Market Size and Growth Rate of Bortezomib
-
3.4.3 Market Size and Growth Rate of Leuprorelin
-
3.4.4 Market Size and Growth Rate of Others
4 Segmentation of Peptide Cancer Vaccine Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Peptide Cancer Vaccine by Major End-Users
-
4.4.1 Market Size and Growth Rate of Peptide Cancer Vaccine in Breast Cancer
-
4.4.2 Market Size and Growth Rate of Peptide Cancer Vaccine in Lung Cancer
-
4.4.3 Market Size and Growth Rate of Peptide Cancer Vaccine in Melanoma
-
4.4.4 Market Size and Growth Rate of Peptide Cancer Vaccine in Prostate Cancer
-
4.4.5 Market Size and Growth Rate of Peptide Cancer Vaccine in Others
5 Market Analysis by Regions
-
5.1 China Peptide Cancer Vaccine Production Analysis by Regions
-
5.2 China Peptide Cancer Vaccine Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Peptide Cancer Vaccine Landscape Analysis
-
6.1 North China Peptide Cancer Vaccine Landscape Analysis by Major Types
-
6.2 North China Peptide Cancer Vaccine Landscape Analysis by Major End-Users
7 Central China Peptide Cancer Vaccine Landscape Analysis
-
7.1 Central China Peptide Cancer Vaccine Landscape Analysis by Major Types
-
7.2 Central China Peptide Cancer Vaccine Landscape Analysis by Major End-Users
8 South China Peptide Cancer Vaccine Landscape Analysis
-
8.1 South China Peptide Cancer Vaccine Landscape Analysis by Major Types
-
8.2 South China Peptide Cancer Vaccine Landscape Analysis by Major End-Users
9 East China Peptide Cancer Vaccine Landscape Analysis
-
9.1 East China Peptide Cancer Vaccine Landscape Analysis by Major Types
-
9.2 East China Peptide Cancer Vaccine Landscape Analysis by Major End-Users
10 Northeast China Peptide Cancer Vaccine Landscape Analysis
-
10.1 Northeast China Peptide Cancer Vaccine Landscape Analysis by Major Types
-
10.2 Northeast China Peptide Cancer Vaccine Landscape Analysis by Major End-Users
11 Southwest China Peptide Cancer Vaccine Landscape Analysis
-
11.1 Southwest China Peptide Cancer Vaccine Landscape Analysis by Major Types
-
11.2 Southwest China Peptide Cancer Vaccine Landscape Analysis by Major End-Users
12 Northwest China Peptide Cancer Vaccine Landscape Analysis
-
12.1 Northwest China Peptide Cancer Vaccine Landscape Analysis by Major Types
-
12.2 Northwest China Peptide Cancer Vaccine Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Generex Biotechnology
-
13.1.1 Generex Biotechnology Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 ISA Pharmaceuticals
-
13.2.1 ISA Pharmaceuticals Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 BrightPath Biotherapeutics
-
13.3.1 BrightPath Biotherapeutics Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Sellas
-
13.4.1 Sellas Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Boston Biomedical
-
13.5.1 Boston Biomedical Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Imugene
-
13.6.1 Imugene Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 VAXON Biotech
-
13.7.1 VAXON Biotech Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Immatics
-
13.8.1 Immatics Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Ultimovacs
-
13.9.1 Ultimovacs Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 TapImmune
-
13.10.1 TapImmune Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
-
13.11 OncoTherapy Science
-
13.11.1 OncoTherapy Science Company Profile and Recent Development
-
13.11.2 Market Performance
-
13.11.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Peptide Cancer Vaccine Market Size and Growth Rate of Goserelin from 2016 to 2027
-
Figure China Peptide Cancer Vaccine Market Size and Growth Rate of Bortezomib from 2016 to 2027
-
Figure China Peptide Cancer Vaccine Market Size and Growth Rate of Leuprorelin from 2016 to 2027
-
Figure China Peptide Cancer Vaccine Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Peptide Cancer Vaccine Market Size and Growth Rate of Breast Cancer from 2016 to 2027
-
Figure China Peptide Cancer Vaccine Market Size and Growth Rate of Lung Cancer from 2016 to 2027
-
Figure China Peptide Cancer Vaccine Market Size and Growth Rate of Melanoma from 2016 to 2027
-
Figure China Peptide Cancer Vaccine Market Size and Growth Rate of Prostate Cancer from 2016 to 2027
-
Figure China Peptide Cancer Vaccine Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Peptide Cancer Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Peptide Cancer Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Peptide Cancer Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Peptide Cancer Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Peptide Cancer Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Peptide Cancer Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Peptide Cancer Vaccine Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Peptide Cancer Vaccine Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Peptide Cancer Vaccine
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Peptide Cancer Vaccine by Different Types from 2016 to 2027
-
Table Consumption Share of Peptide Cancer Vaccine by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Goserelin
-
Figure Market Size and Growth Rate of Bortezomib
-
Figure Market Size and Growth Rate of Leuprorelin
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Peptide Cancer Vaccine by Different End-Users from 2016 to 2027
-
Table Consumption Share of Peptide Cancer Vaccine by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Breast Cancer
-
Figure Market Size and Growth Rate of Lung Cancer
-
Figure Market Size and Growth Rate of Melanoma
-
Figure Market Size and Growth Rate of Prostate Cancer
-
Figure Market Size and Growth Rate of Others
-
Table China Peptide Cancer Vaccine Production by Regions
-
Table China Peptide Cancer Vaccine Production Share by Regions
-
Figure China Peptide Cancer Vaccine Production Share by Regions in 2016
-
Figure China Peptide Cancer Vaccine Production Share by Regions in 2021
-
Figure China Peptide Cancer Vaccine Production Share by Regions in 2027
-
Table China Peptide Cancer Vaccine Consumption by Regions
-
Table China Peptide Cancer Vaccine Consumption Share by Regions
-
Figure China Peptide Cancer Vaccine Consumption Share by Regions in 2016
-
Figure China Peptide Cancer Vaccine Consumption Share by Regions in 2021
-
Figure China Peptide Cancer Vaccine Consumption Share by Regions in 2027
-
Table North China Peptide Cancer Vaccine Consumption by Types from 2016 to 2027
-
Table North China Peptide Cancer Vaccine Consumption Share by Types from 2016 to 2027
-
Figure North China Peptide Cancer Vaccine Consumption Share by Types in 2016
-
Figure North China Peptide Cancer Vaccine Consumption Share by Types in 2021
-
Figure North China Peptide Cancer Vaccine Consumption Share by Types in 2027
-
Table North China Peptide Cancer Vaccine Consumption by End-Users from 2016 to 2027
-
Table North China Peptide Cancer Vaccine Consumption Share by End-Users from 2016 to 2027
-
Figure North China Peptide Cancer Vaccine Consumption Share by End-Users in 2016
-
Figure North China Peptide Cancer Vaccine Consumption Share by End-Users in 2021
-
Figure North China Peptide Cancer Vaccine Consumption Share by End-Users in 2027
-
Table Central China Peptide Cancer Vaccine Consumption by Types from 2016 to 2027
-
Table Central China Peptide Cancer Vaccine Consumption Share by Types from 2016 to 2027
-
Figure Central China Peptide Cancer Vaccine Consumption Share by Types in 2016
-
Figure Central China Peptide Cancer Vaccine Consumption Share by Types in 2021
-
Figure Central China Peptide Cancer Vaccine Consumption Share by Types in 2027
-
Table Central China Peptide Cancer Vaccine Consumption by End-Users from 2016 to 2027
-
Table Central China Peptide Cancer Vaccine Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Peptide Cancer Vaccine Consumption Share by End-Users in 2016
-
Figure Central China Peptide Cancer Vaccine Consumption Share by End-Users in 2021
-
Figure Central China Peptide Cancer Vaccine Consumption Share by End-Users in 2027
-
Table South China Peptide Cancer Vaccine Consumption by Types from 2016 to 2027
-
Table South China Peptide Cancer Vaccine Consumption Share by Types from 2016 to 2027
-
Figure South China Peptide Cancer Vaccine Consumption Share by Types in 2016
-
Figure South China Peptide Cancer Vaccine Consumption Share by Types in 2021
-
Figure South China Peptide Cancer Vaccine Consumption Share by Types in 2027
-
Table South China Peptide Cancer Vaccine Consumption by End-Users from 2016 to 2027
-
Table South China Peptide Cancer Vaccine Consumption Share by End-Users from 2016 to 2027
-
Figure South China Peptide Cancer Vaccine Consumption Share by End-Users in 2016
-
Figure South China Peptide Cancer Vaccine Consumption Share by End-Users in 2021
-
Figure South China Peptide Cancer Vaccine Consumption Share by End-Users in 2027
-
Table East China Peptide Cancer Vaccine Consumption by Types from 2016 to 2027
-
Table East China Peptide Cancer Vaccine Consumption Share by Types from 2016 to 2027
-
Figure East China Peptide Cancer Vaccine Consumption Share by Types in 2016
-
Figure East China Peptide Cancer Vaccine Consumption Share by Types in 2021
-
Figure East China Peptide Cancer Vaccine Consumption Share by Types in 2027
-
Table East China Peptide Cancer Vaccine Consumption by End-Users from 2016 to 2027
-
Table East China Peptide Cancer Vaccine Consumption Share by End-Users from 2016 to 2027
-
Figure East China Peptide Cancer Vaccine Consumption Share by End-Users in 2016
-
Figure East China Peptide Cancer Vaccine Consumption Share by End-Users in 2021
-
Figure East China Peptide Cancer Vaccine Consumption Share by End-Users in 2027
-
Table Northeast China Peptide Cancer Vaccine Consumption by Types from 2016 to 2027
-
Table Northeast China Peptide Cancer Vaccine Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Peptide Cancer Vaccine Consumption Share by Types in 2016
-
Figure Northeast China Peptide Cancer Vaccine Consumption Share by Types in 2021
-
Figure Northeast China Peptide Cancer Vaccine Consumption Share by Types in 2027
-
Table Northeast China Peptide Cancer Vaccine Consumption by End-Users from 2016 to 2027
-
Table Northeast China Peptide Cancer Vaccine Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Peptide Cancer Vaccine Consumption Share by End-Users in 2016
-
Figure Northeast China Peptide Cancer Vaccine Consumption Share by End-Users in 2021
-
Figure Northeast China Peptide Cancer Vaccine Consumption Share by End-Users in 2027
-
Table Southwest China Peptide Cancer Vaccine Consumption by Types from 2016 to 2027
-
Table Southwest China Peptide Cancer Vaccine Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Peptide Cancer Vaccine Consumption Share by Types in 2016
-
Figure Southwest China Peptide Cancer Vaccine Consumption Share by Types in 2021
-
Figure Southwest China Peptide Cancer Vaccine Consumption Share by Types in 2027
-
Table Southwest China Peptide Cancer Vaccine Consumption by End-Users from 2016 to 2027
-
Table Southwest China Peptide Cancer Vaccine Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Peptide Cancer Vaccine Consumption Share by End-Users in 2016
-
Figure Southwest China Peptide Cancer Vaccine Consumption Share by End-Users in 2021
-
Figure Southwest China Peptide Cancer Vaccine Consumption Share by End-Users in 2027
-
Table Northwest China Peptide Cancer Vaccine Consumption by Types from 2016 to 2027
-
Table Northwest China Peptide Cancer Vaccine Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Peptide Cancer Vaccine Consumption Share by Types in 2016
-
Figure Northwest China Peptide Cancer Vaccine Consumption Share by Types in 2021
-
Figure Northwest China Peptide Cancer Vaccine Consumption Share by Types in 2027
-
Table Northwest China Peptide Cancer Vaccine Consumption by End-Users from 2016 to 2027
-
Table Northwest China Peptide Cancer Vaccine Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Peptide Cancer Vaccine Consumption Share by End-Users in 2016
-
Figure Northwest China Peptide Cancer Vaccine Consumption Share by End-Users in 2021
-
Figure Northwest China Peptide Cancer Vaccine Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Generex Biotechnology
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Generex Biotechnology
-
Figure Sales and Growth Rate Analysis of Generex Biotechnology
-
Figure Revenue and Market Share Analysis of Generex Biotechnology
-
Table Product and Service Introduction of Generex Biotechnology
-
Table Company Profile and Development Status of ISA Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of ISA Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of ISA Pharmaceuticals
-
Figure Revenue and Market Share Analysis of ISA Pharmaceuticals
-
Table Product and Service Introduction of ISA Pharmaceuticals
-
Table Company Profile and Development Status of BrightPath Biotherapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of BrightPath Biotherapeutics
-
Figure Sales and Growth Rate Analysis of BrightPath Biotherapeutics
-
Figure Revenue and Market Share Analysis of BrightPath Biotherapeutics
-
Table Product and Service Introduction of BrightPath Biotherapeutics
-
Table Company Profile and Development Status of Sellas
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sellas
-
Figure Sales and Growth Rate Analysis of Sellas
-
Figure Revenue and Market Share Analysis of Sellas
-
Table Product and Service Introduction of Sellas
-
Table Company Profile and Development Status of Boston Biomedical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boston Biomedical
-
Figure Sales and Growth Rate Analysis of Boston Biomedical
-
Figure Revenue and Market Share Analysis of Boston Biomedical
-
Table Product and Service Introduction of Boston Biomedical
-
Table Company Profile and Development Status of Imugene
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Imugene
-
Figure Sales and Growth Rate Analysis of Imugene
-
Figure Revenue and Market Share Analysis of Imugene
-
Table Product and Service Introduction of Imugene
-
Table Company Profile and Development Status of VAXON Biotech
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of VAXON Biotech
-
Figure Sales and Growth Rate Analysis of VAXON Biotech
-
Figure Revenue and Market Share Analysis of VAXON Biotech
-
Table Product and Service Introduction of VAXON Biotech
-
Table Company Profile and Development Status of Immatics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Immatics
-
Figure Sales and Growth Rate Analysis of Immatics
-
Figure Revenue and Market Share Analysis of Immatics
-
Table Product and Service Introduction of Immatics
-
Table Company Profile and Development Status of Ultimovacs
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ultimovacs
-
Figure Sales and Growth Rate Analysis of Ultimovacs
-
Figure Revenue and Market Share Analysis of Ultimovacs
-
Table Product and Service Introduction of Ultimovacs
-
Table Company Profile and Development Status of TapImmune
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of TapImmune
-
Figure Sales and Growth Rate Analysis of TapImmune
-
Figure Revenue and Market Share Analysis of TapImmune
-
Table Product and Service Introduction of TapImmune
-
Table Company Profile and Development Status of OncoTherapy Science
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of OncoTherapy Science
-
Figure Sales and Growth Rate Analysis of OncoTherapy Science
-
Figure Revenue and Market Share Analysis of OncoTherapy Science
-
Table Product and Service Introduction of OncoTherapy Science
-
